Record #36334

Tumor Dependence on the EGFR Signaling Pathway Expressed by the p-EGFR:p-AKT Ratio Predicts Erlotinib Sensitivity in Human Non-small Cell Lung Cancer (NSCLC) Cells Expressing Wild-Type EGFR Gene

Notes from Retraction Watch

date of rettrraction unknown, html page overwrite - date taken from date of journal notification as provided;

Citation lifecycle

How this paper is being cited

Pre-retraction
17
Same day
0
Post-retraction
2
% post-retraction
10.5%
~1.3 citations/yr before retraction · ~0.4 citations/yr after
citing papers

Who is still citing this work

Loading…